Tracie Carroll was Appointed as Director of Legal Operations at La-Jolla-Pharmaceutical

Date of management change: August 16, 2018 

What Happened?

San Diego, -based La-Jolla-Pharmaceutical Appointed Tracie Carroll as Director of Legal Operations


About the Company

La Jolla Pharmaceutical Company is a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies intended to significantly improve outcomes in patients suffering from life-threatening diseases. The Company has several product candidates in development. LJPC-501 is La Jolla`s proprietary formulation of angiotensin II for the potential treatment of catecholamine-resistant hypotension. LJPC-401 is La Jolla`s novel formulation of hepcidin for the potential treatment of conditions characterized by iron overload, such as hereditary hemochromatosis, beta thalassemia, sickle cell disease and myelodysplastic syndrome. LJPC-30S is our next-generation gentamicin derivative program that is focused on therapeutics for the potential treatment of serious bacterial infections as well as rare genetic disorders, such as cystic fibrosis and Duchenne muscular dystrophy.


About the Person

Tracie Carroll is Director of Legal Operations at La Jolla Pharmaceutical. Previously, Tracie held various senior legal leadership roles in the industry.


Info Source



Other IT executives who recently changed jobs as well: Wolf Moore Ilene, Engblom Brandon, Martinez Wolmart Lisa, Rauch Lynn, Austin Deborah, Lagrand Chris, Klauder Jeffrey, Barrow Shannon, Vitek Julie, Krivulka Thomas, Daniels Ed

You can find the full directory of IT executives here.

How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.